175 related articles for article (PubMed ID: 9654084)
21. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
22. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.
Fischer K; Lutz V; Wilhelm O; Schmitt M; Graeff H; Heiss P; Nishiguchi T; Harbeck N; Kessler H; Luther T; Magdolen V; Reuning U
FEBS Lett; 1998 Oct; 438(1-2):101-5. PubMed ID: 9821967
[TBL] [Abstract][Full Text] [Related]
23. Suppression of urokinase-type plasminogen activator expression from human ovarian cancer cells by urinary trypsin inhibitor.
Kobayashi H; Suzuki M; Sun GW; Hirashima Y; Terao T
Biochim Biophys Acta; 2000 Sep; 1481(2):310-6. PubMed ID: 11018722
[TBL] [Abstract][Full Text] [Related]
24. A hybrid protein of the amino-terminal fragment of urokinase and mutant plasminogen activator inhibitor-2 efficiently inhibits tumor cell invasion and metastasis.
Wang X; Hou M; Tan L; Sun X; Zhang Y; Li P; Zhu Y
J Cancer Res Clin Oncol; 2005 Feb; 131(2):129-36. PubMed ID: 15490235
[TBL] [Abstract][Full Text] [Related]
25. Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87).
Magdolen V; Bürgle M; de Prada NA; Schmiedeberg N; Riemer C; Schroeck F; Kellermann J; Degitz K; Wilhelm OG; Schmitt M; Kessler H
Biol Chem; 2001 Aug; 382(8):1197-205. PubMed ID: 11592401
[TBL] [Abstract][Full Text] [Related]
26. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
Kobayashi H; Sugino D; Terao T
Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
[TBL] [Abstract][Full Text] [Related]
27. Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways.
Kobayashi H; Suzuki M; Tanaka Y; Hirashima Y; Terao T
J Biol Chem; 2001 Jan; 276(3):2015-22. PubMed ID: 11050091
[TBL] [Abstract][Full Text] [Related]
28. Differential inhibition of endothelial cell proliferation and migration by urokinase subdomains: amino-terminal fragment and kringle domain.
Kim KS; Hong YK; Lee Y; Shin JY; Chang SI; Chung SI; Joe Y
Exp Mol Med; 2003 Dec; 35(6):578-85. PubMed ID: 14749538
[TBL] [Abstract][Full Text] [Related]
29. Production of a hybrid protein consisting of the N-terminal fragment of urokinase and the C-terminal domain of urinary trypsin inhibitor in Escherichia coli.
Sugino D; Okushima M; Kobayashi H; Terao T
Biotechnol Appl Biochem; 1998 Apr; 27(2):145-52. PubMed ID: 9569610
[TBL] [Abstract][Full Text] [Related]
30. Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.
Magdolen V; Rettenberger P; Koppitz M; Goretzki L; Kessler H; Weidle UH; König B; Graeff H; Schmitt M; Wilhelm O
Eur J Biochem; 1996 May; 237(3):743-51. PubMed ID: 8647121
[TBL] [Abstract][Full Text] [Related]
31. Genetic down-regulation of phosphoinositide 3-kinase by bikunin correlates with suppression of invasion and metastasis in human ovarian cancer HRA cells.
Kobayashi H; Suzuki M; Kanayama N; Terao T
J Biol Chem; 2004 Feb; 279(8):6371-9. PubMed ID: 14597629
[TBL] [Abstract][Full Text] [Related]
32. Suppressing effects of dietary supplementation of soybean trypsin inhibitor on spontaneous, experimental and peritoneal disseminated metastasis in mouse model.
Kobayashi H; Fukuda Y; Yoshida R; Kanada Y; Nishiyama S; Suzuki M; Kanayama N; Terao T
Int J Cancer; 2004 Nov; 112(3):519-24. PubMed ID: 15382080
[TBL] [Abstract][Full Text] [Related]
33. Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.
Fishman DA; Kearns A; Larsh S; Enghild JJ; Stack MS
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):765-9. PubMed ID: 10417342
[TBL] [Abstract][Full Text] [Related]
34. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the metastasis of Lewis lung carcinoma by antibody against urokinase-type plasminogen activator in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Shinohara H; Moniwa N; Terao T
Thromb Haemost; 1994 Apr; 71(4):474-80. PubMed ID: 8052966
[TBL] [Abstract][Full Text] [Related]
36. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
37. Identification and cloning of human placental bikunin, a novel serine protease inhibitor containing two Kunitz domains.
Marlor CW; Delaria KA; Davis G; Muller DK; Greve JM; Tamburini PP
J Biol Chem; 1997 May; 272(18):12202-8. PubMed ID: 9115294
[TBL] [Abstract][Full Text] [Related]
38. Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent.
Kobayashi H; Shinohara H; Gotoh J; Fujie M; Fujishiro S; Terao T
Br J Cancer; 1995 Nov; 72(5):1131-7. PubMed ID: 7577458
[TBL] [Abstract][Full Text] [Related]
39. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity.
Fazioli F; Resnati M; Sidenius N; Higashimoto Y; Appella E; Blasi F
EMBO J; 1997 Dec; 16(24):7279-86. PubMed ID: 9405357
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model.
Kobayashi H; Gotoh J; Fujie M; Shinohara H; Moniwa N; Terao T
Int J Cancer; 1994 Jun; 57(5):727-33. PubMed ID: 8194882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
